Article in Journal ()
Morris M & Cruickshank S (2010) Bisphosphonate-related osteonecrosis of the jaw in cancer patients: Implications for nurses, European Journal of Oncology Nursing, 14 (3), pp. 205-210.
Purpose: This paper reports a review of the literature with a specific focus on osteonecrosis of the jaw. Bisphosphonate drugs are commonly used in the treatment of bone disease secondary to myeloma and solid tumours, such as breast and prostate cancer. In the past few years, an uncommon but distressing condition known as osteonecrosis of the jaw (ONJ) has been detected in patients who are having bisphosphonate treatment, particularly the intravenous (IV) preparations. Osteonecrosis of the jaw results from bone exposure in the oral cavity with subsequent death of bone tissue (necrosis).
bisphosphonic acid derivative; bone density conservation agent, advanced practice nursing; bone necrosis; bone tumor; chemically induced disorder; drug monitoring; human; incidence; jaw disease; metastasis; nurse attitude; nursing; nursing assessment; oncology nursing; organization and management; patient education; practice guideline; primary prevention; review; risk factor, Advanced Practice Nursing; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Drug Monitoring; Humans; Incidence; Jaw Diseases; Nurse's Role; Nursing Assessment; Oncologic Nursing; Osteonecrosis; Patient Education as Topic; Practice Guidelines as Topic; Primary Prevention; Risk Factors
|Authors||Morris Monica, Cruickshank Susanne|
|Publication date online||02/02/2010|
European Journal of Oncology Nursing: Volume 14, Issue 3 (2010)